David Becker, MD, FACC, Director of the Preventive and Integrative Heart Health Program at the Temple Heart and Vascular Institute, wrote a blog post for the Philadelphia Inquirer looking back at the top 10 heart health findings of 2019.
800-TEMPLE-MED
Request Appointment
SEARCH TEMPLE HEALTH
Related News
Dr. Anjali Vaidya Provides Perspective to Healio on FDA Filing Acceptance of New Drug Application for Ralinepag for Treatment of Pulmonary Arterial Hypertension
Posted August 28, 2026Ralinepag is a once-daily oral prostacyclin for the treatment of pulmonary arterial hypertension (PAH).
Read MoreDr. Mohammed Chowdhury Provides Perspective to MedPage Today on New Drug to Prevent Worsening Pulmonary Arterial Hypertension
Posted August 6, 2026Data found oral ralinepag significantly reduced the risk of first clinical worsening in low-risk patients with pulmonary arterial hypertension already receiving contemporary background therapy.
Read More